5:33 PM
Aug 28, 2013
 |  BC Extra  |  Company News

Simcere to go private

Simcere Pharmaceutical Group (NYSE:SCR) said it is going private in a deal in which Chairman Jinsheng Ren and Assure Ahead Investments Ltd. will acquire all of the Simcere shares they do not already own for $4.83 per share in cash or...

Read the full 186 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >